Company 1 identity field
Location
Pasadena, CA
SEC filing record 1 source field
Fiscal year end
30 September
ARROWHEAD PHARMACEUTICALS, INC. has filed 1,347 SEC EDGAR filings since 02 Jan 1998

SEC filing history

Showing 826-850 of 1,000 matching filings.

Per page
25
Current page
34
4

STOCK OPTION GRANT 05/06/2013

Filing date
08 May 2013
Reporting date
06 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STOCK OPTION GRANT 05/06/13

Filing date
08 May 2013
Reporting date
06 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STOCK OPTION GRANT 05/06/13

Filing date
08 May 2013
Reporting date
06 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STOCK OPTION GRANT 05/06/2013

Filing date
08 May 2013
Reporting date
06 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STOCK OPTION DATED 05/06/2013

Filing date
08 May 2013
Reporting date
06 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STOCK OPTION GRANT 05/06/2013

Filing date
08 May 2013
Reporting date
06 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21898

FORM 8-K

Filing date
01 May 2013
Reporting date
29 Apr 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

STOCK OPTION GRANT 03/21/2013

Filing date
01 Apr 2013
Reporting date
21 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

STOCK OPTION GRANT 03/21/2013

Filing date
01 Apr 2013
Reporting date
21 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

STOCK OPTION DATED 03/21/2013

Filing date
01 Apr 2013
Reporting date
21 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

STOCK OPTION GRANT 03/21/2013

Filing date
01 Apr 2013
Reporting date
21 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STOCK OPTION GRANT 03/21/2013

Filing date
25 Mar 2013
Reporting date
21 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STOCK OPTION DATED 03/21/2013

Filing date
25 Mar 2013
Reporting date
21 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STOCK OPTION GRANT 03/21/2013

Filing date
25 Mar 2013
Reporting date
21 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STOCK OPTION GRANT 03/21/2013

Filing date
25 Mar 2013
Reporting date
21 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21898

FORM 8-K

Filing date
25 Mar 2013
Reporting date
21 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21898

FORM 8-K

Filing date
13 Feb 2013
Reporting date
13 Feb 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-21898

DEFINITIVE PROXY STATEMENT

Filing date
04 Feb 2013
Reporting date
21 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21898

FORM 8-K

Filing date
30 Jan 2013
Reporting date
25 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-176159

PROSPECTUS SUPPLEMENT

Filing date
28 Jan 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-48710

SABBY 13G-A ARWR 01.28.13

Filing date
28 Jan 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-176159

PRELIMINARY PROSPECTUS SUPPLEMENT

Filing date
25 Jan 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-48710

SC 13G/A1

Filing date
15 Jan 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .